ZR2 BIOENERGY LIMITED Stock Price Today (NSE: ZR2)
Fundamental Score
ZR2 BIOENERGY LIMITED Share Price — Live NSE/BSE Price, Fundamentals & Analysis
ZR2 BIOENERGY LIMITED share price today is ₹98.45, up +1.41% on NSE/BSE as of 30 March 2026. ZR2 BIOENERGY LIMITED (ZR2) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of ₹108.84 (Cr). The 52-week high for ZR2 share price is ₹437.00 and the 52-week low is ₹92.00. At a P/E ratio of 253.11x, ZR2 is currently trading above its industry average P/E of 20.98x. The company has a Return on Equity (ROE) of 0.09% and a debt-to-equity ratio of 0.00.
ZR2 BIOENERGY LIMITED Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
ZR2 BIOENERGY LIMITED Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
ZR2 BIOENERGY Share Price: A Conservative Value Investor's Perspective
The performance of Commodity Chemicals is frequently influenced by volatile raw material costs and fluctuating demand, creating an environment where margin preservation is paramount. This analysis focuses on ZR2 BIOENERGY share price, currently at ₹151.75, through the lens of a conservative value investor prioritizing capital safety. This analysis forms part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
The current Price-to-Earnings (PE) ratio of 253.11 for ZR2 BIOENERGY LIMITED raises immediate concerns. A high PE suggests the market has elevated expectations for future earnings growth. However, when assessed against its Return on Capital Employed (ROCE) of a mere 0.21%, this valuation appears significantly stretched. A low ROCE indicates the company is not effectively deploying its capital to generate returns, which is a critical red flag for a value investor.
Comparing ZR2 BIOENERGY LIMITED to its peers reveals further insights. For instance,
AG Ventures and other competitors operate within the same sector but might exhibit different levels of operational efficiency and management acumen. While a detailed analysis of AG Ventures’s management quality is beyond the scope here, its comparison helps highlight the need to assess ZR2 BIOENERGY LIMITED's leadership in navigating industry challenges and ensuring shareholder value.The extremely low ROCE of 0.21% directly impacts the company's ability to build a sustainable economic moat. A strong economic moat allows a company to protect its profitability and maintain a competitive advantage. With such a meager return on capital, ZR2 BIOENERGY LIMITED struggles to reinvest in its business, innovate, and defend its market share against competitors. This poses a significant risk to long-term value creation. The ability to generate strong and consistent returns is fundamental to justifying a high valuation. In the case of ZR2 BIOENERGY LIMITED, the current ROCE, coupled with the elevated PE ratio, warrants considerable caution.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
ZR2 BIOENERGY LIMITED Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZR2 across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Excellent EPS Growth (17.52% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (20.48% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (61.00%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.09%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.21%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 253.11x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-66.67%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-118.23 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.06%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
ZR2 BIOENERGY LIMITED Financial Statements
Comprehensive financial data for ZR2 BIOENERGY LIMITED including income statement, balance sheet and cash flow
About ZR2 (ZR2 BIOENERGY LIMITED)
ZR2 BIOENERGY LIMITED is a pioneering force in the commodity chemicals sector, revolutionizing the production of essential resources through sustainable and innovative bioenergy so...lutions. The company is dedicated to transforming organic waste and agricultural byproducts into valuable commodities that fuel industries and contribute to a greener future. ZR2's commitment to environmental stewardship is reflected in its state-of-the-art facilities and proprietary processes, maximizing efficiency and minimizing its carbon footprint. With a focus on quality and consistency, ZR2 Bioenergy delivers a reliable supply of high-grade bio-based products to meet the growing demands of a rapidly evolving market. ZR2 specializes in the manufacturing of three core commodity chemicals: compressed biogas, a clean-burning renewable energy source; ethanol, a versatile biofuel and industrial solvent; and potash, a crucial ingredient in fertilizers that supports global food production. These products are carefully crafted from responsibly sourced biomass, ensuring both environmental integrity and superior performance. Through rigorous research and development, ZR2 continuously refines its production methods to optimize yields and enhance the quality of its offerings. By embracing circular economy principles, ZR2 strives to minimize waste and maximize resource utilization, demonstrating a commitment to sustainable practices across its entire value chain. Rooted in a rich legacy dating back to 1911, ZR2 Bioenergy Limited has evolved from its origins as Gujchem Distillers India Limited to become a leader in the bioenergy revolution. Officially rebranded in May 2025, the company's headquarters remain strategically located in Mumbai, India, a vibrant hub for innovation and commerce. With a deeply ingrained understanding of the local market and a global perspective, ZR2 is poised to capitalize on the growing demand for sustainable commodity chemicals. Its enduring commitment to quality, innovation, and environmental responsibility positions ZR2 Bioenergy Limited as a trusted partner and a driving force in the transition towards a more sustainable future.
Company Details
Key Leadership
Corporate Events
Latest News
ZR2 Share Price: Frequently Asked Questions
What is the current share price of ZR2 BIOENERGY LIMITED (ZR2)?
As of 30 Mar 2026, 12:01 pm IST, ZR2 BIOENERGY LIMITED share price is ₹98.45. The ZR2 stock has a market capitalisation of ₹108.84 (Cr) on NSE/BSE.
Is ZR2 share price Overvalued or Undervalued?
ZR2 share price is currently trading at a P/E ratio of 253.11x, compared to the industry average of 20.98x. Based on this relative valuation, the ZR2 BIOENERGY LIMITED stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of ZR2 share price?
The 52-week high of ZR2 share price is ₹437.00 and the 52-week low is ₹92.00. These values are updated daily from NSE/BSE price data.
What factors affect the ZR2 BIOENERGY LIMITED share price?
Key factors influencing ZR2 share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is ZR2 BIOENERGY LIMITED a good stock for long-term investment?
ZR2 BIOENERGY LIMITED shows a 5-year Profit Growth of 20.48% and an ROE of 0.09%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in ZR2 shares.
How does ZR2 BIOENERGY LIMITED compare with its industry peers?
ZR2 BIOENERGY LIMITED competes with major peers in the Commodity Chemicals. Investors should compare ZR2 share price P/E of 253.11x and ROE of 0.09% against the industry averages to determine competitive standing.
What is the P/E ratio of ZR2 and what does it mean?
ZR2 share price has a P/E ratio of 253.11x compared to the industry average of 20.98x. Investors pay ₹253 for every ₹1 of annual earnings.
How is ZR2 performing according to Bull Run's analysis?
ZR2 has a Bull Run fundamental score of 20.2/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ZR2 belong to?
ZR2 operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting ZR2 BIOENERGY LIMITED share price.
What is Return on Equity (ROE) and why is it important for ZR2?
ZR2 has an ROE of 0.09%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently ZR2 BIOENERGY LIMITED generates profits from shareholders capital.
How is ZR2 debt-to-equity ratio and what does it indicate?
ZR2 has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is ZR2 dividend yield and is it a good dividend stock?
ZR2 offers a dividend yield of 0.03%, meaning you receive ₹0.03 annual dividend for every ₹100 invested in ZR2 BIOENERGY LIMITED shares.
How has ZR2 share price grown over the past 5 years?
ZR2 has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 20.48%, and EPS Growth 17.52%.
What is the promoter holding in ZR2 and why does it matter?
Promoters hold 61.00% of ZR2 shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in ZR2 BIOENERGY LIMITED.
What is ZR2 market capitalisation category?
ZR2 has a market capitalisation of ₹109 crores, placing it in the Small-cap category.
How volatile is ZR2 stock?
ZR2 has a beta of N/A. A beta > 1 suggests the ZR2 BIOENERGY LIMITED stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ZR2 operating profit margin trend?
ZR2 has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is ZR2 quarterly performance?
Recent quarterly performance shows ZR2 BIOENERGY LIMITED YoY Sales Growth of -100.00% and YoY Profit Growth of -66.67%.
What is the institutional holding pattern in ZR2?
ZR2 has FII holding of 0.00% and DII holding of 0.06%. Significant institutional holding often suggests professional confidence in the ZR2 BIOENERGY LIMITED stock.